Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Baudrie

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Neuropharmacology|June 1, 1991
Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucoseV Baudrie, F Chaouloff
European Journal of Pharmacology|March 17, 1992
Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOIV Baudrie, F Chaouloff
European Journal of Pharmacology|June 6, 1991
Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the ratV Baudrie, F Chaouloff
European Journal of Pharmacology|February 20, 1990
Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious ratF Chaouloff, V Baudrie, D Laude
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1992
Differential effects of the novel antidepressant tianeptine on L-5-hydroxytryptophan (5-HTP)-elicited corticosterone release and body weight lossP Broqua, V Baudrie, F Chaouloff
Neuroscience Letters|June 25, 1993
Corticosterone response to the serotonergic agonist D-fenfluramine may be independent from corticotropin-releasing factor (CRF)V Baudrie, C Oliver, F Chaouloff
Neuropharmacology|March 1, 1994
Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxietyF Chaouloff, V Baudrie, I Coupry
European Journal of Pharmacology|October 23, 1990
Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the ratF Chaouloff, D Laude, V Baudrie
European Journal of Pharmacology|August 21, 1990
Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPATF Chaouloff, D Laude, V Baudrie
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1990
Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious ratF Chaouloff, V Baudrie, D Laude
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neuropharmacology|June 1, 1991
Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucoseV Baudrie, F Chaouloff
European Journal of Pharmacology|March 17, 1992
Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOIV Baudrie, F Chaouloff
European Journal of Pharmacology|June 6, 1991
Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the ratV Baudrie, F Chaouloff
European Journal of Pharmacology|February 20, 1990
Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious ratF Chaouloff, V Baudrie, D Laude
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1992
Differential effects of the novel antidepressant tianeptine on L-5-hydroxytryptophan (5-HTP)-elicited corticosterone release and body weight lossP Broqua, V Baudrie, F Chaouloff
Neuroscience Letters|June 25, 1993
Corticosterone response to the serotonergic agonist D-fenfluramine may be independent from corticotropin-releasing factor (CRF)V Baudrie, C Oliver, F Chaouloff
Neuropharmacology|March 1, 1994
Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxietyF Chaouloff, V Baudrie, I Coupry
European Journal of Pharmacology|October 23, 1990
Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the ratF Chaouloff, D Laude, V Baudrie
European Journal of Pharmacology|August 21, 1990
Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPATF Chaouloff, D Laude, V Baudrie
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1990
Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious ratF Chaouloff, V Baudrie, D Laude
Pageof 3